The Weekly US Covid Vax Death and Adverse Events Report By Chris Knight (Florida)
The Centers for Disease Control and Prevention (CDC) Vaccine Adverse Event Reporting System (VAERS), is the principal government-funded system for reporting adverse vaccine reactions in the U.S., but has an under-reporting factor between 41 and 100, according to various authorities. New data shows a total of 1,341,608 reports of adverse events following Covid-19 vaccines were submitted between December 14, 2020, and July 8, 2022. The data included a total of 29,460 reports of deaths — an increase of 187 over last week — and 243,466 serious injuries, including deaths, during the same time period — an increase of 1,566 compared with last week. Of the 29,460 reported deaths, 19,066 cases are attributed to Pfizer’s Covid-19 vaccine, 7,770 cases to Moderna and 2,563 cases to Johnson & Johnson (J&J). The numbers go up steadily each week with no end in sight.
“The Centers for Disease Control and Prevention (CDC) today released new data showing a total of 1,341,608 reports of adverse events following COVID-19 vaccines were submitted between Dec. 14, 2020, and July 8, 2022, to the Vaccine Adverse Event Reporting System (VAERS). That’s an increase of 12,473 adverse events over the previous week.
VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S.
The data included a total of 29,460 reports of deaths — an increase of 187 over the previous week — and 243,466 serious injuries, including deaths, during the same time period — up 1,566 compared with the previous week.
Of the 29,460 reported deaths, 19,066 cases are attributed to Pfizer’s COVID-19 vaccine, 7,770 cases to Moderna and 2,563 cases to Johnson & Johnson (J&J).
Excluding “foreign reports” to VAERS, 842,576 adverse events, including 13,604 deaths and 85,731 serious injuries, were reported in the U.S. between Dec. 14, 2020, and July 8, 2022.
Foreign reports are reports foreign subsidiaries send to U.S. vaccine manufacturers. Under U.S. Food and Drug Administration (FDA) regulations, if a manufacturer is notified of a foreign case report that describes an event that is both serious and does not appear on the product’s labeling, the manufacturer is required to submit the report to VAERS.
Of the 13,604 U.S. deaths reported as of July 8, 15% occurred within 24 hours of vaccination, 19% occurred within 48 hours of vaccination and 58% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.
In the U.S., 597 million COVID-19 vaccine doses had been administered as of July 6, including 353 million doses of Pfizer, 225 million doses of Moderna and 19 million doses of Johnson & Johnson (J&J).
Every Friday, VAERS publishes vaccine injury reports received as of a specified date. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed.
Historically, VAERS has been shown to report only 1% of actual vaccine adverse events.
U.S. VAERS data from Dec. 14, 2020, to July 8, 2022, for 6-month-olds to 5-year-olds show:
- 2,105 adverse events, including 71 cases rated as seriousand 3 reported deaths.
- 4 reportsof myocarditis and pericarditis (heart inflammation).
The CDC uses a narrowed case definition of “myocarditis,” which excludes cases of cardiac arrest, ischemic strokes and deaths due to heart problems that occur before one has the chance to go to the emergency department. - 13 reportsof blood clotting disorders.
- 19 reportsof seizures.
U.S. VAERS data from Dec. 14, 2020, to July 8, 2022, for 5- to 11-year-olds show:
- 11,868 adverse events, including 305 rated as seriousand 8 reported deaths.
The latest reported death (VAERS I.D. #2359520) occurred in an 11-year-old boy from Texas who received two doses of Pfizer’s COVID-19 vaccine. According to his report, the boy died 54 days after his second dose from “COVID-19 infection resulting in Hemorrhagic myocarditis and death.” - 24 reportsof myocarditis and pericarditis.
- 46 reportsof blood clotting disorders.
- 100 reportsof seizures.
U.S. VAERS data from Dec. 14, 2020, to July 8, 2022, for 12- to 17-year-olds show:
- 32,609 adverse events, including 1,845 rated as seriousand 44 reported deaths.
- 62 reportsof anaphylaxis among 12- to 17-year-olds where the reaction was life-threatening, required treatment or resulted in death — with 97% of cases attributed to Pfizer’s vaccine.
- 656 reportsof myocarditis and pericarditis with 644 cases attributed to Pfizer’s vaccine.
- 166 reportsof blood clotting disorders with all cases attributed to Pfizer. VAERS reported 167 cases of blood clotting disorders in the 12- to 17-year-old age group last week.
- 20 casesof postural orthostatic tachycardia syndrome (POTS) with all cases attributed to Pfizer’s vaccine.
U.S. VAERS data from Dec. 14, 2020, to July 8, 2022, for all age groups combined, show:
- 20% of deaths were related to cardiac disorders.
- 54% of those who died were male, 41% were female and the remaining death reports did not include the gender of the deceased.
- The average ageof death was 73.
- As of July 8, 5,643 pregnant womenreported adverse events related to COVID-19 vaccines, including 1,765 reports of miscarriage or premature birth.
- Of the 3,624 cases of Bell’s Palsyreported, 51% were attributed to Pfizer vaccinations, 40% to Moderna and 8% to J&J.
- 900 reports of Guillain-Barré syndrome, with 42% of cases attributed to Pfizer, 30% to Modernaand 27% to J&J.
- 2,291 reportsof anaphylaxis where the reaction was life-threatening, required treatment or resulted in death.
- 1,736 reportsof myocardial infarction.
- 14,200 reportsof blood-clotting disorders in the U.S. Of those, 6,348 reports were attributed to Pfizer, 5,088 reports to Moderna and 2,717 reports to J&J.
- 4,263 casesof myocarditis and pericarditis with 2,612 cases attributed to Pfizer, 1,448 cases to Moderna and 187 cases to J&J.
- 14 casesof Creutzfeldt-Jakob disease with 8 cases attributed Pfizer, 5 cases to Moderna and 1 case to J&J.
- 269 casesof POTS with 165 cases attributed to Pfizer, 86 cases to Moderna and 17 cases to J&J.”
Comments